Navigation Links
Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports

Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now... -- DALLAS, November 1, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Publishing & Information Services, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Surveys, Polls and Research, Economic News, Trends, Analysis Click to view news release full screen  

Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports


DALLAS, November 1, 2010 /PRNewswire/ -- ReportsandReports announces it will carry Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Research Report in its store.

Browse the complete Report on: pipeline-assessment-and-marke.html

Browse All Manufacturing & Construction Reports:

Browse All GlobalData Research Reports at

GlobalData, the industry analysis specialist, has released its new report, "Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global PAD market. The report identifies the key trends shaping and driving the global PAD market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global PAD sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The global PAD therapeutics market accounted for approximately $606m in 2009. In 2001, the market was valued at $405m and it grew at an approximate CAGR of 5.2% between 2001 and 2009. The global PAD therapeutics market is expected to reach $1 billion by 2017 growing at a CAGR of 6.5% between 2009 and 2017. The primary factor contributing to the increase in growth over the forecast period is the increase in disease incidence and the launch of new first-in-class drugs. Presently the therapeutic regimen for PAD consists of antiplatelet agents such as clopidogrel (Plavix) and ticlopidine (Ticlid). Blood thinners such as pentoxifyline (Trental) and Cilostazol (Pletal) are also prescribed. Like most cardiovascular complications, aspirin is used as a complementary drug in combination with the above mentioned drugs.


The report provides information on the key drivers and challenges of the PAD market. Its scope includes: - Annualized global PAD market revenues data from 2001 to 2009, forecast for eight years to 2017. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as of gene therapy, stem cell therapy, platelet aggregation inhibitor, Hydroxymethylglutaryl-CoA reductase inhibitor, monoclonal antibody, micro RNA, protein kinase modulator, Y2 agonist, and PPAR (Peroxisome Proliferator Activated Receptor) agonist. - Analysis of the current and future competition in the global PAD market. Key market players covered are Sanofi Aventis, Indigo pharmaceuticals, BioMarin Pharmaceutical, and AnGes MG Inc. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the PAD therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to: - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global PAD market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global PAD market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What's the next big thing in the global PAD market landscape? - Identify, understand and capitalize.

Browse All Specific Markets:

Browse All Latest Reports:

Related Reports

Peripheral Arterial Disease (PAD) - Drug Pipeline Analysis and Market Forecasts to 2016 ( drug-pipeline-analysis-and-ma.html)

Peripheral Arterial Disease Therapy Area Pipeline Report ( apy-area-pipeline-report.html)

Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017 ( essment-and-market-forecasts-to-.html)

Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017 ( ssessment-and-market-forecast-to.html)

Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017 ( ssessment-and-market-forecasts-t.html)

Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts to 2017 ( eline-assessment-and-market-for.html)

Anemia - Pipeline Assessment and Market Forecasts to 2017 ( arket-forecasts-to-2017.html)

Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market Forecasts to 2017 ( peline-assessment-and-market-.html)

Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017 ( ssessment-and-market-forecasts-t.html)

Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 ( enopause-pipeline-assessment-an.html)

(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact: Ms. Sunita 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Peripheral Artery Disease (PAD) Patent Granted to Dimera
2. CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors
3. Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant
4. ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons
5. Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States
6. Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care
7. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
8. Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinsons Disease
9. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
10. 550 People Across Europe Will Die Today From a Preventable Lung Disease
11. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of a New Dermal Patch for Parkinsons Disease
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... year and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual ... November 2015, where ISPE hosted the largest number of attendees in more than ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... the explosion of technology-enabled health and wellness, and the ... book, The Internet of Healthy Things ... or smartphones even existed, Dr. Kvedar, vice president, Connected ... health care delivery, moving care from the hospital or ...
Breaking Biology News(10 mins):